Javascript must be enabled to continue!
Positively charged liposomal β-carotene enhances irradiation-induced cytotoxicity against prostate carcinoma cells: an in-vitro study
View through CrossRef
Abstract
Interactions of β-carotene in the absence or presence of stearylamine (SA, positive charge inducer) with liposomes as model membranes were characterized. The morphology of all liposomes was almost spherical in shape, well dispersed and less aggregated for empty and encapsulated vesicles. The mean particle size distribution of empty liposomal samples was clustered around 43.82 ± 21.29 nm. The presence of SA in liposomal membranes decreased the density of negative charge, resulting in a positive zeta potential. The introduction of β-carotene or β-carotene mixed with SA into liposomes exhibited a shift to higher temperature. FTIR study confirmed the interaction of β-carotene or β-carotene mixed with SA with the liposome’s moieties. In the absence of external gamma irradiation, the IC₅₀ value for free β-carotene in PC-3 cells was 29.24 µg/ml, whereas positively charged liposomal β-carotene showed an IC₅₀ of 34.74 µg/ml, indicating slightly greater cytotoxicity of the free form when used alone. However, under combined treatment with 5 Gy gamma irradiation, the IC₅₀ for positively charged liposomal β-carotene was markedly reduced to 11.66 µg/ml compared with 32.46 µg/ml for free β-carotene, demonstrating the superior cytotoxic effect of the charged liposomal formulation in the presence of irradiation. Flow cytometric analysis revealed that after 48 h of exposure to positively charged liposomal β-carotene. The treatment with the IC50 of positively charged liposomal β-carotene resulted in (58.14% and 33.67%) followed by liposomal β-carotene (51.52% and 43.66%) cell accumulation in the G0-G1 and S phases, respectively. The current findings demonstrated that natural product preparations could be a viable therapy option for prostate cancer in place of pharmaceutical therapies.
Springer Science and Business Media LLC
Title: Positively charged liposomal β-carotene enhances irradiation-induced cytotoxicity against prostate carcinoma cells: an in-vitro study
Description:
Abstract
Interactions of β-carotene in the absence or presence of stearylamine (SA, positive charge inducer) with liposomes as model membranes were characterized.
The morphology of all liposomes was almost spherical in shape, well dispersed and less aggregated for empty and encapsulated vesicles.
The mean particle size distribution of empty liposomal samples was clustered around 43.
82 ± 21.
29 nm.
The presence of SA in liposomal membranes decreased the density of negative charge, resulting in a positive zeta potential.
The introduction of β-carotene or β-carotene mixed with SA into liposomes exhibited a shift to higher temperature.
FTIR study confirmed the interaction of β-carotene or β-carotene mixed with SA with the liposome’s moieties.
In the absence of external gamma irradiation, the IC₅₀ value for free β-carotene in PC-3 cells was 29.
24 µg/ml, whereas positively charged liposomal β-carotene showed an IC₅₀ of 34.
74 µg/ml, indicating slightly greater cytotoxicity of the free form when used alone.
However, under combined treatment with 5 Gy gamma irradiation, the IC₅₀ for positively charged liposomal β-carotene was markedly reduced to 11.
66 µg/ml compared with 32.
46 µg/ml for free β-carotene, demonstrating the superior cytotoxic effect of the charged liposomal formulation in the presence of irradiation.
Flow cytometric analysis revealed that after 48 h of exposure to positively charged liposomal β-carotene.
The treatment with the IC50 of positively charged liposomal β-carotene resulted in (58.
14% and 33.
67%) followed by liposomal β-carotene (51.
52% and 43.
66%) cell accumulation in the G0-G1 and S phases, respectively.
The current findings demonstrated that natural product preparations could be a viable therapy option for prostate cancer in place of pharmaceutical therapies.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract
The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein, which our group first cloned and characterized in myeloid cells and mapp...
Nature Products Enhance NKG2D Ligands Expression of CD123+CD34+CD38− Leukemia Stem Cells for Stimulating Cytotoxicity of NKG2D+ Cells to Themselves
Nature Products Enhance NKG2D Ligands Expression of CD123+CD34+CD38− Leukemia Stem Cells for Stimulating Cytotoxicity of NKG2D+ Cells to Themselves
Abstract
CD123+CD34+CD38− leukemia cells regarded as leukemia stem cells, not only refractory to chemotherapeutics but also resistant to immune response such as cyto...
Holmium laser enucleation of the prostate versus bipolar transurethral enucleation of the prostate in management of benign prostatic hyperplasia: A randomized controlled trial
Holmium laser enucleation of the prostate versus bipolar transurethral enucleation of the prostate in management of benign prostatic hyperplasia: A randomized controlled trial
Objective
To evaluate the safety, efficacy and cost‐effectiveness of holmium enucleation of the prostate and bipolar transurethral enucleation of the prostate.
...
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract
Background: Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide. It is the third most common cancer in men in Algeri...
Data from Dietary Fructose Promotes Prostate Cancer Growth
Data from Dietary Fructose Promotes Prostate Cancer Growth
<div>Abstract<p>Clinical localization of primary tumors and sites of metastasis by PET is based on the enhanced cellular uptake of 2-deoxy-2-[<sup>18</sup>F...
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract
BACKGROUND: Multiple steps and factors are involved in prostate carcinogenesis and tumor progression. The early studies have found that tumor-associated mac...

